CJC-1295 (No Dac) + Ipamorelin (Blend) 5/5mg

CJC-1295 (No DAC) + Ipamorelin 5/5mg is one of the most popular peptide blends in a research context, designed with a focus on the natural stimulation of growth hormone, recovery, sleep quality, and the improvement of body composition. Thanks to the synergy between a GHRH analogue and a GH secretagogue, this combination is considered one of the most balanced approaches to supporting the GH axis.

What is the CJC-1295 (No DAC) + Ipamorelin 5/5mg peptide blend?

CJC-1295 (No DAC) + Ipamorelin 5/5mg is a highly effective peptide blend developed in a research context to support the natural release of growth hormone through two complementary mechanisms of action. The combination pairs CJC-1295 without DAC, which acts as a GHRH analogue and signals the pituitary gland, with Ipamorelin – a selective GH secretagogue that activates ghrelin receptors and enhances the GH response via a parallel pathway.

This dual formula is designed to provide a fuller, more balanced, and more physiological stimulus to the GH axis compared to using a single molecule. Instead of externally administering hormone, the blend works by stimulating the body's own hormonal system, which makes it particularly popular in settings focused on recovery, body composition, sleep quality, and anti-aging strategies.

The CJC-1295 version without DAC is preferred by many users because it provides shorter action and a more natural pulsatile pattern, closer to normal growth hormone secretion. Adding Ipamorelin complements this effect by enhancing GH release without the typical strong appetite profile seen with some older GHRP peptides.

It is precisely because of this synergy that CJC-1295 (No DAC) + Ipamorelin 5/5mg remains one of the most sought-after peptide blends in research protocols aimed at recovery, regeneration, fat reduction, maintenance of lean muscle mass, and optimization of hormonal balance.

Composition and role of the individual components of the CJC-1295 (No DAC) + Ipamorelin 5/5mg peptide blend?

CJC-1295 (No DAC) – 5 mg is a synthetic analogue of GHRH, the natural hormone that signals the pituitary gland to release growth hormone. The version without DAC is preferred in protocols aimed at shorter action and a more physiological pulsatile pattern, closer to the body's natural secretion. Its main role in the blend is to activate the GH axis naturally, supporting recovery, sleep quality, body composition, and hormonal rhythm without prolonged signal accumulation.

Ipamorelin – 5 mg is a selective GH secretagogue that stimulates the release of growth hormone via the ghrelin receptors (GHS-R1a). It is considered one of the most balanced molecules in its class, as it targets GH secretion with a cleaner profile compared to older GHRP peptides. Within the blend, its role is to amplify the signal for growth hormone release via a second, parallel mechanism, complementing the action of CJC-1295.

The combination of the two components is particularly effective because they operate through different receptor pathways. CJC-1295 stimulates GHRH receptors, while Ipamorelin activates ghrelin receptors. It is this synergy that creates a fuller and more balanced stimulus for the natural release of growth hormone, making the blend so popular in protocols focused on recovery, sleep, body composition, and anti-aging strategies.

What are the benefits of the CJC-1295 (No DAC) + Ipamorelin peptide blend?

• Supports the release of growth hormone

The combination works by stimulating endogenous GH secretion rather than through external hormonal administration. This makes it a preferred option in research protocols that pursue a physiological approach.

• Improves sleep quality

GH pulses are closely linked to deep sleep. For this reason the blend is often considered in connection with better overnight recovery and higher quality sleep.

• Faster recovery

Growth hormone plays a key role in recovery processes. The formula is often used in settings aimed at shorter recovery periods after exertion.

• Support for body composition

Interest in the combination is also related to assisting fat reduction and maintaining lean body mass.

• Improves tone and recovery capacity

Some protocols aim for a better sense of recovery, tone, and adaptation to stress.

• Balanced GH approach

The combination is known for providing a strong but more controlled signal compared to more aggressive GH secretagogues.

• Clinical and scientific data

The blend itself is a combined formula, but the individual ingredients are well-documented in the literature.

Research on CJC-1295 and Ipamorelin examines:

• increased GH secretion
• increased IGF-1
• improved recovery
• impact on body composition
• improved sleep
• better hormonal rhythm

It is the synergy between the GHRH and GHS-R pathways that is the reason this combination is so popular.

Proper administration and dosage within a research protocol of the CJC-1295 (No DAC) + Ipamorelin peptide blend

It is typically administered by subcutaneous injection after proper reconstitution.

In research practice, a common daily range of 200 to 600 mcg is often used, divided into one or two doses depending on the specific protocol.

Most commonly administration is in the evening or morning and evening, depending on the goals.

Cycle durations typically range between 8 and 16 weeks, after which a break is often planned.

Possible side effects of the CJC-1295 (No DAC) + Ipamorelin peptide blend

Most common:

• mild redness at the injection site
• temporary fatigue
• mild headache
• water retention

Less common:

• mild hunger
• dizziness
• individual sensitivity

In most cases the reactions are mild and short-lived.

The information on this website has been collected and summarized from multiple scientific studies and analyses.

It is for informational purposes only and is not intended for diagnosing, treating, or preventing disease.

The products offered on the site are not classified as medicinal products or medical devices and are intended solely for laboratory and research purposes.